AcelRx Pharmaceuticals, Inc. ACRX was a big mover last session, as its shares rose nearly 12% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Jul 3, as the stock is now down over 12%.
In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate moved slightly higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
AcelRx Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the med-drugs industry include Enanta Pharmaceuticals, Inc. ENTA, Endo International plc ENDP and Ironwood Pharmaceuticals, Inc. IRWD. All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACELRX PHARMACT ACRX: Free Stock Analysis Report
ENANTA PHARMA ENTA: Free Stock Analysis Report
ENDO INTL PLC ENDP: Free Stock Analysis Report
IRONWOOD PHARMA IRWD: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate moved slightly higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
AcelRx Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the med-drugs industry include Enanta Pharmaceuticals, Inc. ENTA, Endo International plc ENDP and Ironwood Pharmaceuticals, Inc. IRWD. All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACELRX PHARMACT ACRX: Free Stock Analysis Report
ENANTA PHARMA ENTA: Free Stock Analysis Report
ENDO INTL PLC ENDP: Free Stock Analysis Report
IRONWOOD PHARMA IRWD: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
